Summary
Despite a marked reduction of the urea cycle capacity, patients with well-compensated chronic liver disease excrete near-normal amounts of urea. Compensation of the urea cycle defect apparently occurs through the activation of liver glutaminase, as suggested by an inverse relationship between the in vitro ureagenic capacity and the flux through glutaminase in liver tissue from patients with a normal, fatty, or cirrhotic liver. In these patients, the flux through glutaminase, as determined in vitro, increases in parallel with the plasma bicarbonate level and plasma pH determined in vivo. In view of this and results from previous studies, the following hypothesis is suggested: The decrease of urea cycle enzyme activities in liver cirrhosis produces metabolic alkalosis due to an impaired bicarbonate elimination. Alkalosis in turn activates and stabilizes hepatic glutaminase and accordingly mitochondrial ammonia provision for carbamoylphosphate synthetase. This results in a compensatory stimulation of the urea cycle flux in the cirrhotic patient to near-normal rates, despite the marked reduction of urea cycle enzyme activity. Accordingly, alkalosis is an important driving force for urea synthesis in the cirrhotic patient. With respect to clinical medicine, attention must be paid to acid-base disturbances in the hyperammonemic patient.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ansley JD, Isaacs JW, Rikkers LF, Kutner MH, Nordlinger BM, Rudman D (1978) Quantitative test for nitrogen metabolism in cirrhosis: relation to other manifestations of liver disease. Gastroenterology 75:570–579
Bergmeyer HU (ed) (1974) Methoden der Enzymatischen Analyse. Verlag Chemie, Weinheim
Dölle W (1965) Der Säurebasenhaushalt bei Leberzirrhose. A. Hüthig, Heidelberg
Gerok W, Häussinger D (1987) Neukonzeption der systemischen Säurebasenregulation — die Bedeutung der Leber. Internist 27:429–436
Haag G, Holldorf AW, Gerok W (1972) Veränderungen der Argininosuccinatsynthetase-Aktivität in der Leber bei chronischen Lebererkrankungen. Klin Wochenschr 50:887–889
Häussinger D (1990) Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J 267:281–290
Häussinger D, Gerok W, Sies H (1983) Regulation of flux through glutaminase and glutamine synthetase in isolated perfused rat liver. Biochim Biophs Acta 755:272–278
Häussinger D, Meijer AJ, Gerok W, Sies H (1988) Hepatic nitrogen metabolism and acid-base homeostasis. In: Häussinger D (ed) pH homeostasis. Academic Press, London, pp 337–377
Häussinger D, Steeb R, Gerok W (1990) Ammonium and bicarbonate homeostasis in chronic liver disease. Klin Wochenschr 68:175–182
Häussinger D, Steeb R, Kaiser S, Wettstein M, Stoll B, Gerok W (1990) Nitrogen metabolism in normal and cirrhotic liver. In: Grisolia S (ed) Cirrhosis, hepatic encephalopathy and ammonium toxicity. Plenum Press, New York pp 47–64
Jungermann K, Katz N (1989) Functional specialization of different hepatocyte populations. Physiol Rev 69:708–764
Kaiser S, Gerok W, Häussinger D (1988) Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonemia in chronic liver disease. Eur J Clin Invest 18:535–542
Kathra BS, Smith RB, Milikan W, Sewell CW, Warren WD, Rudman D (1974) Activities of Krebs-Henseleit enzymes in normal and cirrhotic human liver. J Lab Clin Med 84:708–715
Maier TP, Talke A, Gerok W (1979) Activities of urea cycle enzymes in chronic liver disease. Klin Wochenschr 57:661–664
McGivan JD, Boon K, Doyle FA (1991) Glucagon and ammonia infuence the long-term regulation of phosphate-dependent glutaminase activity in primary cultures of rat hepatocytes. Biochem J 274:103–108
McGivan JD, Doyle FA, Boon K (1991) Factors influencing the inactivation of phosphate-dependent glutaminase in the matrix fraction of rat liver mitochondria. Biochem J 274:109–114
Meijer AJ, Lof C, Ramos I, Verhoefen AJ (1985) Control of ureogenesis. Eur J Biochem 148:189–196
Oster JR (1983) Acid-base homeostasis and liver disease. In: Epstein M (ed) The kidney in liver disease. Elsevier Science, New York, pp 147–182
Oster JR, Perez GO (1986) Acid-base disturbances in liver disease. J Hepatol 2:299–306
Pierson DL, Brien JM (1980) Human carbamoylphosphate synthetase I. J Biol Chem 255:7891–7895
Rubio V, Ramponi G, Grisolia S (1981) Carbamoylphosphate synthetase I from human liver. Purification, some properties and immunological cross-reactivity with the rat liver enzyme. Biochem Biophys Acta 659:150–160
Rudman D, DiFulco JT, Galambos JT, Smith R, Slam A, Warren WD (1973) Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest 52:2241–2249
Rypins EB, Henderson JM (1980) A tracer method for measuring rate of urea synthesis in normal and cirrhotic subjects. Gastroenterol 78:1419–1424
Schwab M, Damaschke H (1962) Atmung, Säure-Basen-Gleichgewicht und Ammoniak/Ammonium in Blut und Liquor cerebrospinalis bei Leberzirrhose. Klin Wochenschr 40:184–199
Snodgrass PJ, Lund P (1984) Allosteric properties of phosphate-activated glutaminase of human liver mitochondria. Biochim Biophys Acta 798:21–27
Traber PG, Chianale J, Gumucio JJ (1988) Physiologic significance and regulation of hepatocellular heterogeneity. Gastroenterology 95:1130–1143
Ugarte G, Pine, ME, Valenzuela J, Lorca F (1963) Urea cycle enzymatic abnormalities in patients with endogenous hepatic coma. Gastroenterol 45:182–188
Vilstrup H (1988) Synthesis of urea after stimulation with amino acids: relation to liver function. Gut 21:990–995
Author information
Authors and Affiliations
Additional information
This study was supported by Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 154 „Experimentelle und Klinische Hepatologie”, the Schilling-Stiftung and Fonds der Chemischen Industrie
Rights and permissions
About this article
Cite this article
Häussinger, D., Steeb, R. & Gerok, W. Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications. Clin Investig 70, 411–415 (1992). https://doi.org/10.1007/BF00235522
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00235522